,

Do Peptides Affect Fertility?

A man and a woman sitting side by side in a clinical setting, surrounded by background illustrations of cellular biology and the hypothalamic-pituitary-gonadal axis.

Some peptides affect fertility, and the ones with human fertility data are prescription medicines used inside a fertility clinic. Nothing sold as a dietary supplement belongs in that category, and no supplement is studied for or intended to affect conception, eggs, or sperm.

That covers part of the question most people ask. The skipped piece matters more if you are trying to conceive right now, because peptides and hormones taken for weight, recovery, or hormonal goals act on the same signaling pathway that fertility drugs act on.

If you are trying to conceive, pregnant, or nursing, review everything you take with your clinician before you add or continue anything. That includes supplements, especially anything bought from a source that cannot show you what is in the vial.

The peptides with human fertility data are prescription drugs, including GnRH analogs, hCG, FSH, and kisspeptin in clinical trials, all given under medical supervision.

No dietary supplement, peptide, or otherwise, is studied for or intended to affect conception, egg quality, or sperm quality.

A more practical question is how to support a healthy reproductive system, since compounds taken for weight, muscle, or hormonal goals can act on the reproductive axis.

Anyone trying to conceive should review their full list with a clinician, because the reproductive safety data does not exist yet for many research peptides.

The Peptides With Fertility Data Are Prescription Medicines

Fertility medicine has run on peptides for decades, and every one of them is a drug. They are injected, prescribed by a specialist, and monitored with bloodwork and ultrasound while they work.

Here is what clinics use.

Peptide medicineWhat it does in fertility careHow it is used
GnRH agonists and antagonistsControl the timing of the natural LH surge, so egg retrieval can be scheduledPrescription injection during an IVF cycle
hCGTriggers final egg maturation, and in men supports testosterone production inside the testisPrescription injection
Recombinant FSHDrives follicle growth during ovarian stimulationPrescription injection
KisspeptinInvestigational trigger for egg maturation, studied as an alternative to hCGHospital research trials only

None of these is sold in a capsule, and none is a dietary supplement. One category is a molecule with an approved indication and a clinician deciding when you need it.

A review of ovulation trigger strategies makes the point plainly: choosing between hCG and a GnRH agonist is a case-by-case clinical judgment based on the patient’s response, not a category anyone should self-select from.

How the Reproductive Axis Works

A flow diagram detailing the signaling cascade from Kisspeptin (Node 1) through the Hypothalamus (Node 2) and Pituitary (Node 3) down to the Gonads (Node 4).

Reproduction runs on a three-stop chain of command, and peptides sit at the top. That chain explains both why the fertility drugs work and why unrelated compounds can interfere.

The hypothalamus releases GnRH in pulses. GnRH tells the pituitary to release LH and FSH. LH and FSH travel to the ovaries or testes and drive ovulation, egg maturation, testosterone production, and sperm development.

Sitting above all of that is kisspeptin, a peptide that switches the GnRH neurons on in the first place. Anything that changes kisspeptin or GnRH signaling changes everything downstream.

Small peptides can therefore produce large reproductive effects, because they act on a control system rather than on an organ directly. That works in reverse too, since a compound aimed at appetite or growth hormone can land on the same hypothalamic circuit by accident.

Peptide bioregulators, the short tissue-derived complexes sold in capsules, work on a different principle entirely. Our explainer on what peptide bioregulators are covers how that category is built and what it is designed to do.

Kisspeptin, and Why Fertility Researchers Use It

Kisspeptin is the most interesting peptide in reproductive medicine right now, and it is not available outside of a clinical trial.

In a Phase 2 randomized controlled trial in 62 women at high risk of ovarian hyperstimulation syndrome, researchers used kisspeptin-54 to trigger final egg maturation during IVF. Adding a second injection about 10 hours after the first raised the proportion of patients reaching a good egg yield from 45 percent to 71 percent, without pushing more women into ovarian over-response.

The safety comparison is what’s important to clinicians. In a single-center study of 261 women at high risk of ovarian hyperstimulation syndrome, the odds of being diagnosed with it were roughly 34 times higher after an hCG trigger and about 4 times higher after a GnRH agonist trigger, compared with kisspeptin.

That makes kisspeptin a promising line of research, but it is injected, given in hospital, and measured against blood hormone levels in real time. Kisspeptin sold on a website is not the compound in those trials, and a capsule is not the delivery route behind those results.

How To Think Differently About Fertility Support: Peptides Taken for Something Else

An infographic outlining the distinction between clinical prescription peptides used for fertility under specialist care and over-the-counter dietary supplements.

For most readers, the more useful direction is to start at your baseline: whether something already in your routine is acting on your reproductive axis. Three examples have human data behind them.

Testosterone and the Rejuvenation Clinic Blind Spot

Exogenous testosterone suppresses sperm production, and a lot of men taking it do not know that.

A review in Fertility and Sterility on hormones used in rejuvenation clinics found that testosterone and anabolic androgenic steroids shut down the intratesticular testosterone the testis needs to make sperm, which can lead to severely reduced sperm counts or none at all. The effect is usually reversible after stopping, and a companion review reports that most men return to normal sperm production within a year of discontinuing.

The authors were blunt about why this happens. Men who want children later in life often have no idea that the hormone protocol they signed up for at an anti-aging clinic works, in this respect, like a contraceptive.

Growth Hormone Secretagogues and the LH Signal

Growth hormone secretagogues act at the ghrelin receptor, and ghrelin has a documented inhibitory effect on the reproductive axis in humans.

In a controlled study in seven healthy young men, infusing acylated ghrelin reduced LH output by about 40 percent and abolished LH pulsatility altogether. The pituitary still responded normally to direct GnRH, which told researchers the block was happening centrally, above the pituitary.

That is mechanistic human data on ghrelin itself, not evidence that any particular product does the same thing. It is the kind of finding you should raise with a fertility specialist and not try to work out on your own.

GLP-1 Medications and the Conception Window

GLP-1 receptor agonists are peptides, and they can affect reproduction.

A 2026 narrative review reports that these medications can restore ovulation and menstrual regularity in women with obesity or PCOS, which raises the chance of conception, sometimes unexpectedly. That is why contraceptive counseling has become a standard part of prescribing them.

The picture is not uniformly favorable. A real-world cohort of 1,936 women with infertility found that semaglutide use in the year before fertility care was associated with lower and slower pregnancy and live birth rates than matched controls, a finding the authors flagged as needing prospective confirmation. On the pregnancy side, a meta-analysis of six studies covering 286,599 women found no increase in major congenital malformations after exposure around conception, while cautioning that the data are observational and not proof of safety.

These three findings point in different directions, which means the question is still being investigated. 

What Peptide Bioregulators Can Do, and What They Can’t

Peptide bioregulators are short peptides isolated from specific tissues and sold in capsules to support normal function of the organ system they came from. They are dietary supplements, they contain no hormones, and they are not fertility products.

Don’t confuse the peptide bioregulators as fertility products just because the category includes complexes drawn from ovarian and testicular tissue, and the naming invites the wrong inference. Peptide bioregulators can support normal tissue function as part of a healthy aging routine; however, that is a different claim from affecting conception.

The research behind the category is mechanistic. Work on how ultrashort peptides cross cell membranes describes transporter families that can carry two- and three-amino-acid peptides into cells, which is the proposed route by which a capsule reaches tissue. Reproductive-system findings in this family are mostly preclinical. In animal research, for instance, pineal peptide preparations have been studied for their effect on disrupted reproductive cycling in rats, which is rodent data on circadian signaling rather than any human outcome.

Two BioLongevity complexes are built for organ-system support in this space:

  • BioMale (GPL Man) is a natural geroprotector peptide complex formulated to support the function of the endocrine and reproductive systems in males.
  • BioFemale (GPL Femme) is the female counterpart, formulated to support vascular, endocrine, and female reproductive system function.

Both are structure and function support for healthy aging. Neither is a fertility product; neither is intended to affect conception or gamete quality; and neither replaces care from a clinician. If you want the wider view of the category by goal, our guide to the best hormone peptides for women sorts the options by the strength of the human evidence behind each one.

What To Do If You Are Trying To Conceive

Start by writing down everything you take, then take that list to the clinician managing your care. Prescriptions, supplements, and anything ordered online all belong on your list, because the interactions may not be obvious from a label.

A few things make that conversation more productive:

  • Sperm takes roughly 70 to 90 days to develop, so a change made today shows up in a semen analysis a season from now, not next week.
  • Hormones, weight-loss medications, and research peptides all reach the same axis, even when they were prescribed for something unrelated.
  • If a product cannot show you independent lab documentation of what is in it, you cannot tell your clinician what you are taking. Every BioLongevity batch has a published Certificate of Analysis you can read before you order.
  • For most research peptides circulating in the wellness world, nobody has run a reproductive safety study. Absent data doesn’t mean a substance is safe.

Younger women often come to this topic through general wellness rather than conception planning. We cover it separately in our guide to peptides for premenopausal women.

Frequently Asked Questions

These questions about fertility, peptides, and supplements come up often, and we’ve got some straight answers to the most popular ones.

Do peptides affect fertility in men?

Yes, some do. Exogenous testosterone and anabolic androgenic steroids suppress sperm production, which is well documented, and clinicians use hCG specifically to protect testicular function. Peptide dietary supplements are a separate category and are not studied for or intended to affect sperm or fertility.

Can peptide supplements help me get pregnant?

No. No dietary supplement is studied for, intended for, or permitted to claim any effect on conception. The peptides used to support conception are prescription medicines given inside a fertility clinic.

Is kisspeptin available as a supplement?

No. Kisspeptin has been studied as an injected trigger for egg maturation in hospital-run IVF trials. It is not an approved medicine for general use, and it is not a dietary supplement ingredient.

Are peptide bioregulators safe while trying to conceive?

Consult your clinician about using peptide bioregulators if you’re trying to conceive. Bioregulators are dietary supplements without fertility research behind them, and anyone trying to conceive, pregnant, or nursing should clear every supplement with the clinician managing their care first.

Do peptides affect sperm count?

Testosterone and anabolic steroids do reduce sperm count. Growth hormone secretagogues act at a receptor shown in human research to suppress LH signaling, which is upstream of sperm production. Whether that translates into a measurable change in sperm count from any given product has not been established.

Can I take a peptide supplement while pregnant or nursing?

Not without clearing it with your clinician. Peptide supplements have not been studied in pregnancy or lactation, so it’s essential to consult your clinician.

Read More From the BioLongevity Blog

If you’re after organ-system support for healthy aging, BioMale (GPL Man) is the men’s geroprotector complex built for endocrine and reproductive system function, and the full hormone and organ health collection covers the same job across other systems. Every formula is third-party tested with batch documentation you can read before you buy, which is the standard worth insisting on while the science in this category is still being written.

Ask a qualified clinician before starting any supplement if you are pregnant, nursing, trying to conceive, taking medication, or managing a medical condition.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.


References

  1. Abbara A, Clarke S, Islam R, et al. A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial. Human Reproduction. 2017;32(9):1915-1924. DOI
  2. Abbara A, Islam R, Clarke SA, et al. Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatment. Clinical Endocrinology. 2018;88(6):920-927. DOI
  3. Dosouto C, Haahr T, Humaidan P. Advances in ovulation trigger strategies. Panminerva Medica. 2019;61(1):42-51. DOI
  4. Moss JL, Crosnoe LE, Kim ED. Effect of rejuvenation hormones on spermatogenesis. Fertility and Sterility. 2013;99(7):1814-1820. DOI
  5. Crosnoe LE, Grober E, Ohl D, Kim ED. Exogenous testosterone: a preventable cause of male infertility. Translational Andrology and Urology. 2013;2(2):106-113. DOI
  6. Lanfranco F, Bonelli L, Baldi M, Me E, Broglio F, Ghigo E. Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis. The Journal of Clinical Endocrinology and Metabolism. 2008;93(9):3633-3639. DOI
  7. Abedi MM, Patni MM, Shajahan ANB, et al. GLP-1 receptor agonists, fertility restoration, and reproductive safety in women of reproductive age: a narrative review. Journal of Clinical Medicine. 2026;15(9):3204. DOI
  8. Wu YC, Hsu JC, Su EC, Chen CH, Chang TH. Impact of semaglutide pretreatment on reproductive outcomes in women with overweight and obesity with infertility: a real-world multicenter cohort study. Reproductive Biology and Endocrinology. 2026;24(1):55. DOI
  9. Liu X, Xiong B, Yang R, Wang H, Liu Y. Periconceptional use of GLP-1 receptor agonists and the risk of major congenital malformations: a systematic review and meta-analysis. Endocrine Connections. 2026;15(7). DOI
  10. Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. Transport of biologically active ultrashort peptides using POT and LAT carriers. International Journal of Molecular Sciences. 2022;23(14):7733. DOI
  11. Arutjunyan A, Kozina L, Milyutina Y, Korenevsky A, Stepanov M, Arutyunov V. Melatonin and pineal gland peptides are able to correct the impairment of reproductive cycles in rats. Current Aging Science. 2012;5(3):178-185. DOI